Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Indivior Pharmaceuticals Inc. (INDV) vs Lantheus Holdings, Inc. (LNTH)

Indivior Pharmaceuticals Inc. and Lantheus Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. Lantheus Holdings, Inc. is the larger, with a market value of $6.5B against $4.3B — 1.5× the size. Indivior Pharmaceuticals Inc. trades at the lower P/E: 12.4× against 23.7×. Indivior Pharmaceuticals Inc. grew revenue faster over the last twelve months: 13.5% against 2.35%. Indivior Pharmaceuticals Inc. has the higher net margin (26.8% vs 17.7%) and the higher return on invested capital (460.5% vs 14.7%). Across the 19 metrics below, Indivior Pharmaceuticals Inc. leads on 14 and Lantheus Holdings, Inc. on 5.

Valuation

Metric INDV LNTH Drug Manufacturers Specialty & Generic median
P/E 12.40 23.69 20.14
P/S 3.20 4.18 2.25
P/B n/m 4.95 1.90
Price to free cash flow n/m 16.54 16.54
EV/EBITDA 10.43 16.38 12.29
EV/Sales 3.42 4.16 2.56
Earnings yield 8.07% 4.22% (2.99%)
Free cash flow yield (2.65%) 6.04% 0.00%

Profitability

Metric INDV LNTH Drug Manufacturers Specialty & Generic median
Gross margin 81.97% 60.14% 53.94%
Operating margin 31.56% 19.43% 0.00%
Net margin 26.75% 17.69% 0.00%
Free cash flow margin (8.34%) 25.24% 0.00%
Return on equity (153.12%) 22.21% (0.40%)
Return on assets 26.52% 12.15% (3.32%)
Return on invested capital 460.53% 14.65% 0.00%

Growth

Metric INDV LNTH Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 13.47% 2.35% 10.01%
EPS growth (last fiscal year) 3,017.87% (21.79%) —
Revenue growth, 5-year CAGR 13.88% 35.35% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INDV LNTH Drug Manufacturers Specialty & Generic median
Debt to equity (2.34) 0.44 0.05
Current ratio 0.84 3.06 2.31
Net debt to EBITDA 0.44 0.55 0.85

Dividend

Metric INDV LNTH Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio — 0.00 0.00

Size

Metric INDV LNTH Drug Manufacturers Specialty & Generic median
Market cap 4.25b 6.51b 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack